Interest in Ergomed's blood thickener 'significant' - CEO Miroslav Reljanovic, Ergomed 00:00:00

Share On Facebook Share On Twitter

Miroslav Reljanovic, chief executive of Ergomed Plc (LON:ERGO), tells Proactive they've brought forward the reporting date for top-line results for their phase-IIb trial of blockbuster blood thickening agent PeproStat.

Recent Videos